Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CMT1A duplicated region transcript 15-like 2 pseudogene (ENSG00000267441) is a pseudogene, defined as a genomic DNA sequence similar to a normal gene but nonfunctional due to disabling mutations or lack of regulatory elements. Pseudogenes can arise by gene duplication or retrotransposition; those termed "duplicated region" likely originate from gene duplication events. These loci do not encode functional protein products, but some may be transcribed into RNA and participate in regulatory functions at the RNA level, including acting as potential microRNA decoys. However, most pseudogenes—including this one—are not considered therapeutic targets, and no drugs or therapeutic interventions are directed toward them. There are no recognized safety concerns, biomarker uses, or clinical associations specific to this locus. ENSG00000267441 is a pseudogene, not a protein-coding gene or therapeutic target. It does not interact with drugs, is not linked to a defined biological function or disease, and has no known clinical relevance beyond its categorization as a noncoding genomic element.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CMT1A duplicated region transcript 15-like 2 pseudogene (ENSG00000267441).